Related Experiment Video
Updated: Jan 3, 2026

Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
Myc/Max dependent intronic long antisense noncoding RNA, EVA1A-AS, suppresses the expression of Myc/Max dependent
Svenja E Niehus1, Aldrige B Allister1, Andrea Hoffmann2
1Institut fuer Biochemie, OE4310, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, D-30623, Hannover, Germany.
Abstract:
The Myc gene has been implicated in the pathogenesis of most types of human cancerous tumors. Myc/Max activates large numbers of pro-tumor genes; however it also induces anti-proliferation genes. When anti-proliferation genes are activated by Myc, cancer cells can only survive if they are downregulated. Hepatocellular carcinoma (HCC) specific intronic long noncoding antisense (lnc-AS) RNA, the EVA1A-AS gene, is located within the second intron (I2) of the EVA1A gene (EVA-1 homolog A) that encodes an anti-proliferation factor. Indeed, EVA1A, but not EVA1A-AS, is expressed in normal liver. Depletion of EVA1A-AS suppressed cell proliferation of HepG2 cells by upregulation of EVA1A. Overexpression of EVA1A caused cell death at the G2/M phase via microtubule catastrophe. Furthermore, suppressed EVA1A expression levels are negatively correlated with differentiation grade in 365 primary HCCs, while EVA1A-AS expression levels are positively correlated with patient survival. Notably, both EVA1A and EVA1A-AS were activated by the Myc/Max complex. Eva1A-AS is transcribed in the opposite direction near the 3'splice site of EVA1A I2. The second intron did not splice out in a U2 dependent manner and EVA1A mRNA is not exported. Thus, the Myc/Max dependent anti-proliferating gene, EVA1A, is controlled by Myc/Max dependent anti-sense noncoding RNA for HCC survival.
Insights
The Myc gene drives cancer by activating both pro-tumor and anti-proliferation genes. In liver cancer (HCC), EVA1A-AS RNA controls the anti-proliferation gene EVA1A, crucial for cancer cell survival.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- The Myc/Max complex plays a dual role in cancer, activating pro-tumor genes while also inducing anti-proliferation genes.
- Hepatocellular carcinoma (HCC) survival depends on downregulating Myc-induced anti-proliferation genes.
- EVA1A, an anti-proliferation factor, is encoded by the EVA1A gene, with its antisense long noncoding RNA (lnc-AS) EVA1A-AS located in its second intron.
Purpose of the Study:
- To investigate the role of the EVA1A-AS lnc-AS RNA in hepatocellular carcinoma (HCC) pathogenesis.
- To elucidate the regulatory relationship between EVA1A, EVA1A-AS, and the Myc/Max complex in HCC.
Main Methods:
- Analysis of EVA1A and EVA1A-AS expression in HCC tissues and cell lines.
- Gene depletion and overexpression studies in HepG2 cells.
- Correlation analysis between gene expression levels, differentiation grade, and patient survival in HCC cohorts.
Main Results:
- EVA1A-AS depletion upregulated EVA1A, suppressing HepG2 cell proliferation.
- EVA1A overexpression induced G2/M phase cell death via microtubule catastrophe.
- Suppressed EVA1A expression correlated with poor differentiation in HCC, while EVA1A-AS expression correlated with better patient survival.
- Both EVA1A and EVA1A-AS were identified as Myc/Max targets.
Conclusions:
- The Myc/Max complex regulates the anti-proliferation gene EVA1A and its antisense lnc-AS RNA EVA1A-AS in HCC.
- EVA1A-AS acts as a crucial regulator for HCC cell survival by controlling EVA1A expression.
- EVA1A-AS represents a potential therapeutic target for hepatocellular carcinoma.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
MicroRNAs
MicroRNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Abnormal Proliferation

